Lindbrook Capital, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$4,088
-51.4%
627
-35.1%
0.00%
-100.0%
Q1 2024$8,414
-36.0%
966
-15.9%
0.00%0.0%
Q4 2023$13,145
+398.1%
1,149
+319.3%
0.00%
Q3 2023$2,639
-53.0%
274
-48.1%
0.00%
-100.0%
Q2 2023$5,618
+116.2%
528
+113.8%
0.00%
Q1 2023$2,598
+103.6%
247
+139.8%
0.00%
Q4 2022$1,276
+27.6%
1030.0%0.00%
Q3 2022$1,0000.0%103
+145.2%
0.00%
Q1 2022$1,000420.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$183,240,00017.56%
HealthInvest Partners AB 1,450,000$16,211,00012.91%
Healthcare Value Capital, LLC 200,000$2,236,0004.98%
BRIDGER MANAGEMENT, LLC 2,852,414$31,890,0002.98%
Camber Capital Management LP 7,500,000$83,850,0002.88%
13D Management LLC 658,017$7,357,0002.72%
Brown Capital Management 20,170,126$225,502,0001.68%
Healthcare Value Capital, LLC 50,000$559,0001.24%
Zebra Capital Management LLC 59,122$661,0000.73%
PRICE MICHAEL F 520,000$5,814,0000.70%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders